PMID,Title,Journal,Year
39407867,Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration.,Journal of clinical medicine,2024
37436681,Direct-Acting Antivirals and the Risk of Arrhythmias and Conduction Disorders in Patients with Chronic Hepatitis C: A French Nationwide Cohort Study.,Drugs,2023
36103593,Safe co-administration of direct-acting antivirals and direct oral anticoagulants among patients with hepatitis C virus infection: An international multicenter retrospective cohort study.,Journal of viral hepatitis,2022
32613565,"Assessing the impact of a combination of sofosbuvir and daclatasvir treatment for hepatitis C virus infection on heart rate, rhythm and heart rate variability using 24-hour ECG monitoring.",The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology,2020
32611956,Severe Bradycardia Induced by Sofosbuvir and Amiodarone which Resolved after the Discontinuation of Both Drugs.,"Internal medicine (Tokyo, Japan)",2020
28596225,Increased warfarin requirements in a patient with chronic hepatitis C infection receiving sofosbuvir and ribavirin.,American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,2017
27974712,Outcome of Combination Therapy with Sofosbuvir and Ledipasvir for Chronic Type C Liver Disease.,Oncology,2017
